<DOC>
	<DOCNO>NCT01016002</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Foscan ( temoporfin ) photodynamic therapy treatment locally advance perihilar bile duct carcinoma without distant metastasis .</brief_summary>
	<brief_title>Single-arm Study Photodynamic Laser Therapy Using Foscan Non-curatively-resectable Bile Duct Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Ductal</mesh_term>
	<mesh_term>Bile Duct Neoplasms</mesh_term>
	<mesh_term>Temoporfin</mesh_term>
	<criteria>bile duct carcinoma proven histology advance nonoperable stage tumor extension : 1 . Bismuth type III IV ( resectable R0margins ) 2 . Bismuth type I II , resective surgery contraindicate old age poor surgical risk patient sufficient general condition undergo PDT ( Karnofsky status &gt; 30 % ) age &gt; 19 year access common bile duct ( either via endoscopy sphincterotomy percutaneously transhepatic drainage ) , inform write consent porphyria disease exacerbate light know intolerance allergy porphyrin derivative plan surgical procedure within next 30 day coexist ophthalmic disease likely require slit lamp examination within next 30 day impair kidney liver function ( creatinine &gt; 2.5x elevate , INR &gt; 2.2 vitamin K ) , leukopenia ( WBC &lt; 2000/cmm ) thrombopenia ( &lt; 50000/cmm ) , cytotoxic chemotherapy within past 4 week . pregnancy ( safe contraception 6 month PDT ) accompanying/complicating disease poor prognosis ( expect survival &lt; 6 week ) , proven advance peritoneal carcinomatosis ( PET scan imaging , ascites positive tumor cell )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>